ADVENTRX Pharmaceuticals Financial Statements
ADVENTRX Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
ADVENTRX Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.5 | 0.0 | 0.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (24.3) | (29.8) | (13.2) |
| Total Net Income ($ mil.) | (22.1) | (29.3) | (24.8) |
| Diluted EPS (Net Income) | (0.25) | (0.40) | (0.41) |
ADVENTRX Pharmaceuticals Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (6.2) | (5.8) | (6.4) |
| Total Net Income ($ mil.) | (5.9) | (5.4) | (5.9) |
| Diluted EPS (Net Income) | (0.07) | (0.06) | (0.07) |
ADVENTRX Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.77 | 1.54 |
| Price/Earnings Ratio | -- | 15.99 | 15.14 |
| Price/Book Ratio | 1.33 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | -- | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ADVENTRX Pharmaceuticals Financial Ratios
ADVENTRX Pharmaceuticals Competitive Intelligence
| GlaxoSmithKline | Roche | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 45,816.1 | 34,465.2 | 43,019.0 |
| Employees | -- | 74,372 | 99,495 |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape
